PDMR Notification RSU Vesting
PureTech Health plc announced that 33% of restricted share units granted on June 26, 2024, vested on June 26, 2026, and were issued to directors and PDMRs on July 14, 2026. The market price used for calculation was 119.20 pence per ordinary share, with an exchange rate of £1: $1.34. Following this issuance, the company's total issued ordinary share capital is 257,927,489 shares, with 14,030,193 held in treasury. Eric Elenko received 56,735 shares, Michael Inbar received 30,245 shares, and Charles Sherwood received 37,001 shares, all at a price of 0.01 GBP per share.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PDMR Notifications
PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company") a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, announces that awards of restricted share units ("RSUs") granted by PureTech on 26 June 2024 to certain directors and other persons discharging managerial responsibilities ("PDMRs") pursuant to its Performance Share Plan ("PSP") 33% of the shares vested on 26 June 2026 and were subsequently issued to the PDMRs noted below.
Each PDMR received vested ordinary shares (after deduction of shares for payroll taxes) on 14 July 2026. The market price per ordinary share in the Company used to calculate the amount payable to the PDMRs and the amount of shares to be issued to PDMRs was 119.20 pence, being the average closing price of the Company's shares over the three-trading day period immediately prior to issuance, and the exchange rate used to calculate the cash payment and amount of share settlement was £1: $1.34.
PDMR Notification
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Eric Elenko Michael Inbar Charles Sherwood |
| 2 | Reason for the notification | |
| a) | Position/status | Eric Elenko - President Michael Inbar - Chief Accounting Officer Charles Sherwood - Chief Operating Officer, General Counsel and Corporate Secretary |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| c) | Price(s) and volume(s) | Recipient Price Amount Eric Elenko 0.01 GBP 56,735 ordinary shares Michael Inbar 0.01 GBP 30,245 ordinary shares Charles Sherwood 0.01 GBP 37,001 ordinary shares |
| e) | Date of the transaction | 14 J uly 2026 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.